Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Danaher Corp. (DHR)
NYSE:DHR
Holding DHR?
Track your performance easily
DHR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$215.68 - $281.70
Previous Close$233.1
Volume1.35M
Average Volume (3M)2.58M
Market Cap
$167.35B
Enterprise Value$184.26B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$17.52B
Price to Earnings (P/E)44.0
Beta0.87
Next Earnings
Feb 04, 2025EPS Estimate
$2.14Last Dividend Ex-Date
Sep 27, 2024Dividend Yield0.45%
Share Statistics
EPS (TTM)5.24
Shares Outstanding722,275,141
10 Day Avg. Volume3,192,673
30 Day Avg. Volume2,580,850
Standard Deviation0.07
R-Squared0.37
Alpha0.00446
Financial Highlights & Ratios
Price to Book (P/B)3.28
Price to Sales (P/S)7.02
Price to Cash Flow (P/CF)27.60
P/FCF Ratio32.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.20
Enterprise Value/Gross Profit13.13
Enterprise Value/Ebitda29.50
Forecast
1Y Price Target
$290.06Price Target Upside23.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
Danaher News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceStronger revenues and better operating margins resulted in adjusted EPS beating consensus estimates.
Growth And InnovationLong-term secular growth drivers combined with positioning toward emerging high-growth markets including neuro, infectious disease and oncology should drive sustainable growth.
Market PositionDHR is viewed as a leader in the attractive market of bioprocess tools, maintaining its position as a diversified consolidator in life science tools and diagnostics.
Bears Say
Market Challenges In ChinaChina's market remains weak with no expectation of near-term improvement due to stimulus uncertainty and funding concerns.
Slow Recovery In Bioprocess SectorThe recovery in the bioprocess sector is too gradual to support high single-digit core growth in 2025.
Valuation ConcernsConcerns exist on the pace of revenue growth improvement and valuation, with shares trading at a 25% premium to peers on an EPS basis.
---
Ownership Overview
4.06% Insiders
26.94% Mutual Funds
21.47% Other Institutional Investors
30.10% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DHR FAQ
What was Danaher Corp.’s price range in the past 12 months?
Danaher Corp. lowest stock price was $215.68 and its highest was $281.70 in the past 12 months.
What is Danaher Corp.’s market cap?
Currently, no data Available
When is Danaher Corp.’s upcoming earnings report date?
Danaher Corp.’s upcoming earnings report date is Feb 04, 2025 which is in 75 days.
How were Danaher Corp.’s earnings last quarter?
Danaher Corp. released its earnings results on Oct 22, 2024. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.569 by $0.141.
Is Danaher Corp. overvalued?
According to Wall Street analysts Danaher Corp.’s price is currently Undervalued.
Does Danaher Corp. pay dividends?
Danaher Corp. pays a Quarterly dividend of $0.27 which represents an annual dividend yield of 0.45%. See more information on Danaher Corp. dividends here
What is Danaher Corp.’s EPS estimate?
Danaher Corp.’s EPS estimate is $2.14.
How many shares outstanding does Danaher Corp. have?
Danaher Corp. has 722,275,150 shares outstanding.
What happened to Danaher Corp.’s price movement after its last earnings report?
Danaher Corp. reported an EPS of $1.71 in its last earnings report, beating expectations of $1.569. Following the earnings report the stock price went down -3.973%.
Which hedge fund is a major shareholder of Danaher Corp.?
Among the largest hedge funds holding Danaher Corp.’s share is Fisher Asset Management LLC. It holds Danaher Corp.’s shares valued at 1B.
---
Danaher Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$290.06 (23.97% Upside)
$290.06 (23.97% Upside)
Blogger Sentiment
Bullish
DHR Sentiment 91%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 445.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $255.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.7%
Last 30 Days ▲ 9.0%
Last 30 Days ▲ 9.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
10.91%
12-Months-Change
Fundamentals
Return on Equity
7.59%
Trailing 12-Months
Asset Growth
-8.11%
Trailing 12-Months
Company Description
Danaher Corp.
Founded in 1969 and headquartered in Washington, DC, Danaher Corp. engages in manufacturing, designing and marketing of professional, medical, industrial and commercial products and services. The company operates through three segments, including Life Sciences, Diagnostics, and Environmental & Applied Solutions.
---
DHR Company Deck
---
DHR Earnings Call
Q3 2024
0:00 / 0:00
---
DHR Revenue Breakdown
40.09% Diagnostics
30.02% Biotechnology
29.89% Life Sciences
---
DHR Stock 12 Month Forecast
Average Price Target
$290.06
▲(23.97% Upside)
Technical Analysis
Best Analysts Covering DHR
1 Year
1 Year Success Rate
11/13 ratings generated profit
1 Year Average Return
+25.52%
upgraded a buy rating 18 days ago
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +25.52% per trade.
---